A new study suggests current vaccines and monoclonal antibody therapies provide less neutralizing activity against the U.K. and South Africa variants of SARS-CoV-2. View original article here Source
- Tuesday
- April 20th, 2021
A new study suggests current vaccines and monoclonal antibody therapies provide less neutralizing activity against the U.K. and South Africa variants of SARS-CoV-2. View original article here Source